Mallinckrodt Pharmaceuticals

Joel L. Dunn is a distinguished leader in pharmaceutical compliance, currently serving as the director of controlled substance compliance analytics at Mallinckrodt Pharmaceuticals. With a robust legal background and over two decades of experience in regulatory enforcement, Dunn fortifies systems that detect and prevent drug diversion, ensuring adherence to both federal and state regulations.

A Visionary at the Intersection of Law and Pharmaceutical Compliance

Joel L. Dunn’s career is defined by a steadfast commitment to maintaining the integrity of pharmaceutical practices. He began his career in pharmaceutical compliance with over 16 years of experience at the U.S. Drug Enforcement Administration, where he held leadership roles including diversion group supervisor and staff coordinator. During his tenure, he oversaw multi-jurisdictional and international investigations and provided subject matter expertise in pharmaceutical law and online diversion.

Upon transitioning to the private sector, Dunn applied his extensive public-sector experience to strengthen Mallinckrodt’s compliance strategies. His ability to fuse legal acumen with data-driven approaches has enhanced the SOMS, embedded analytics into compliance processes, and established new standards for informed, proactive decision-making.

Previously, as manager of controlled substance compliance at Mallinckrodt, Dunn played a key role in developing SOMS, performing due diligence, and supporting inspections of registered facilities. These efforts were critical in identifying diversion risks and maintaining regulatory alignment.

“His ability to fuse legal acumen with data-driven approaches has enhanced the SOMS, embedded analytics into compliance processes and established new standards for informed, proactive decision-making”

Now, he leads initiatives in data analytics and regulatory compliance, with a focus on managing SOMS, conducting investigations and applying statistical modeling across departments.

Providing Mentorship Rooted in Experience

In addition to his organizational impact, Dunn is known for his dedication to education and mentorship. He has led numerous training sessions for law enforcement and industry professionals, promoting a culture of compliance and ethical responsibility.

Holding a doctorate in jurisprudence from Texas Wesleyan University, Dunn is widely respected for his legal insight, investigative expertise and strategic leadership. With the pharmaceutical landscape continually evolving, he remains a leading force in advancing initiatives that safeguard public health through robust compliance and data-driven innovation.